KELLY ROBINSON: Open Payments
NPI 1689933236 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,094 in 30 payments from 6 companies in 2025. Trend: 2023 $561 · 2024 $9,719 · 2025 $12,094
Speaker / faculty: $10,981Travel & lodging: $565Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $11,879 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Alkermes, Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: UZEDY, INGREZZA, AUSTEDO XR, ARISTADA, ABILIFY ASIMTUFII, INVEGA, COBENFY.
Industry payments across LA — which companies pay providers there.
